Stay updated on bb21217 Efficacy in Myeloma Clinical Trial
Sign up to get notified when there's something new on the bb21217 Efficacy in Myeloma Clinical Trial page.

Latest updates to the bb21217 Efficacy in Myeloma Clinical Trial page
- CheckyesterdayChange DetectedAdded links to Multiple myeloma and MedlinePlus Genetics, and updated the page revision from v3.4.2 to v3.4.3.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedRevision: v3.4.2 was added and the prior Revision: v3.4.1 tag was removed. Related topics such as 'Multiple myeloma' and 'MedlinePlus Genetics' were also removed.SummaryDifference0.2%

- Check31 days agoChange DetectedThe page now lists new related topics (Multiple myeloma and MedlinePlus Genetics) and shows a revision update from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check38 days agoChange DetectedThe update adds a glossary display option and updates header labels (including Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0) on the study record page. The core study information remains unchanged.SummaryDifference0.2%

- Check45 days agoChange DetectedDeleted the term 'Multiple myeloma' and its related topic 'MedlinePlus Genetics' from the page's related topics.SummaryDifference0.2%

- Check52 days agoChange DetectedAdded related topics such as Multiple myeloma and MedlinePlus Genetics, and updated the revision from v3.3.3 to v3.3.4.SummaryDifference0.2%

Stay in the know with updates to bb21217 Efficacy in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the bb21217 Efficacy in Myeloma Clinical Trial page.